Plasma and liver lipidomics response to an intervention of rimonabant in ApoE*3Leiden.CETP transgenic mice.

Lipids are known to play crucial roles in the development of life-style related risk factors such as obesity, dyslipoproteinemia, hypertension and diabetes. The first selective cannabinoid-1 receptor blocker rimonabant, an anorectic anti-obesity drug, was frequently used in conjunction with diet and...

Full description

Bibliographic Details
Main Authors: Chunxiu Hu, Heng Wei, Anita M van den Hoek, Mei Wang, Rob van der Heijden, Gerwin Spijksma, Theo H Reijmers, Jildau Bouwman, Suzan Wopereis, Louis M Havekes, Elwin Verheij, Thomas Hankemeier, Guowang Xu, Jan van der Greef
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3096625?pdf=render